Magnesium Sulfuricum Bbp

Magnesium sulfate, the active ingredient in Magnesium Sulfuricum Bbp, is a magnesium compound presented as an injectable solution for intramuscular, intravenous and subcutaneous use. It is classified as a magnesium replacement therapy and is employed to correct magnesium deficiency, manage eclampsia or pre‑eclampsia, and treat cardiac arrhythmias associated with low magnesium levels.

GNH USA supplies Magnesium Sulfuricum Bbp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Magnesium Sulfate is used in clinical situations where magnesium repletion is required, particularly affecting electrolyte balance and neuromuscular stability. - Magnesium deficiency: restores normal serum magnesium concentrations. - Hypomagnesemia: corrects low magnesium levels to prevent related complications. - Eclampsia/pre‑eclampsia: reduces seizure risk in pregnant patients. - Torsades de pointes: stabilizes cardiac repolarisation. - Cardiac arrhythmias related to low magnesium: normalises cardiac rhythm.

Adverse reactions may occur with magnesium sulfate administration.

Common Side Effects: - Flushing or warmth at the injection site. - Nausea or vomiting. - Headache. - Dizziness or light‑headedness. - Sweating.

Serious or Rare Side Effects: - Hypotension or severe blood pressure drop. - Hypermagnesemia leading to respiratory depression. - Cardiac arrest or severe arrhythmias. - Allergic reactions including anaphylaxis. - Muscle weakness or loss of deep tendon reflexes.

Magnesium sulfate requires careful clinical monitoring. - Serum magnesium monitoring: check levels before and during therapy. - Renal function assessment: adjust use in patients with impaired clearance. - Hypermagnesemia avoidance: discontinue if serum magnesium exceeds therapeutic range. - Cardiac conduction caution: monitor ECG in patients with existing conduction disorders. - Elderly dosing: consider reduced dosage due to increased sensitivity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magnesium sulfate can interact with several medications, influencing safety and efficacy.

Major Interactions (Avoid): - Neuromuscular blocking agents: may potentiate muscle relaxation. - Calcium channel blockers: can enhance hypotensive effects. - Other magnesium‑containing products: risk of hypermagnesemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may increase serum potassium and affect renal function. - Digoxin: altered electrolyte balance can modify cardiac effects. - Quinine: magnesium may reduce quinine efficacy.